Company: DARE
Filing Date: 2025-04-24
Form Type: ARS
Source: 0001401914-25-000018
Chunk: 323

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: ARS
Chunk 323
---
 requests a hearing before the Nasdaq Hearing Panel (the “Panel”). On February 20, 2025, the Company requested a hearing before the Panel, which request stayed the delisting of its common stock pending the decision of the Panel following the hearing and the expiration of any extension period that may be granted by the Panel. The hearing occurred on March 25, 2025. Pursuant to published Nasdaq guidance, the Panel typically issues it decision within 30 days of the hearing. There can be no assurance that the Panel will grant the Company any extension period within which to regain compliance with the Minimum MVLS Rule, or if any extension period is granted, that the Company will regain compliance with the Minimum MVLS Rule within such extension period, or that the Company will be successful in otherwise maintaining the listing of our common stock on The Nasdaq Capital Market. F-37